Amyotrophic lateral sclerosis

27Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Abstract Amyotrophic lateral sclerosis (ALS) is a common neurological disorder that results in loss of motor neurons, leading to a rapidly progressive form of muscle paralysis that is fatal. There is no available cure and current therapies only provide minimal benefit at best. The disease is predominantly sporadic and until very recently only the Cu,Zn superoxide dismutase (Cu,ZnSOD), which is involved in a small number of sporadic cases and a larger component of familial ones, have been analyzed in any detail. Here we describe the clinical aspects of ALS and highlight the genetics and molecular mechanisms behind the disease. We discuss the current understanding and controversies of how mutations in Cu,ZnSOD may cause the disease. We also focus on the recent discovery that mutations in either TDP-43 or FUS/TLS, which are both involved in DNA/RNA synthesis, are likely the cause behind many cases of ALS that are not linked to Cu,ZnSOD. © 2010 Landes Bioscience and Springer Science+Business Media.

Cite

CITATION STYLE

APA

Perry, J. J. P., Shin, D. S., & Tainer, J. A. (2010). Amyotrophic lateral sclerosis. Advances in Experimental Medicine and Biology, 685, 9–20. https://doi.org/10.1007/978-1-4419-6448-9_2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free